Advertisement

Topics

STAT Plus: Pharmalittle: New ALS drug raises concerns; will Glaxo face bribery charges in the UK?

09:42 EDT 11 Aug 2017 | STAT

The first new drug for amyotrophic lateral sclerosis, or ALS, in 22 years was approved by U.S. regulators this week, causing excitement but also concerns.

Original Article: STAT Plus: Pharmalittle: New ALS drug raises concerns; will Glaxo face bribery charges in the UK?

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: New ALS drug raises concerns; will Glaxo face bribery charges in the UK?"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...